| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Newamsterdam Pharma Co N.V. (NAMS) has 11 insiders with recent SEC Form 4 filings, including 2 buys and 23 sells. NAMS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 3.03M | $83.80M | - | |
| CEO | 378.9K | $10.48M | - | |
| Other | 99.0K | $2.74M | - | |
| CFO | 58.4K | $1.62M | - | |
| Other | 24.4K | $673.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 24, 2024 | Forgrowth Nap B.V.50 | 10% Owner | Sell | 91,068 | $25.58 | $2,329,520.01 | -0.2% | -7.5% | +37.4% | |
| Dec 19, 2024 | Forgrowth Nap B.V.50 | 10% Owner | Sell | 157,234 | $25.86 | $4,066,713.80 | -0.5% | -7.3% | +37.9% | |
| Dec 17, 2024 | Forgrowth Nap B.V.50 | 10% Owner | Sell | 115,480 | $25.95 | $2,996,156.01 | -0.3% | -12.3% | +26.6% | |
| Dec 13, 2024 | Forgrowth Nap B.V.50 | 10% Owner | Sell | 191,762 | $25.34 | $4,859,875.24 | -0.6% | -4.5% | +50.9% | |
| Dec 11, 2024 | Forgrowth Nap B.V.50 | 10% Owner | Sell | 462,288 | $25.40 | $11,740,617.80 | -0.8% | -10.5% | +41.5% | |
| Nov 18, 2024 | Forgrowth Nap B.V.50 | 10% Owner | Sell | 41,803 | $25.07 | $1,047,876.21 | -0.2% | -18.7% | +57.8% | |
| Nov 14, 2024 | Forgrowth Nap B.V.50 | 10% Owner | Sell | 10,898 | $25.01 | $272,510.63 | - | -22.4% | +53.6% | |
| Oct 1, 2024 | Kooij Louise Frederika | Chief Accounting Officer | Sale+OE | 45,000 | $15.72 | $707,400.00 | -100% | +48.1% | +69.8% | |
| Sep 26, 2024 | Audet Juliette Berangere | Chief Business Officer | Buy | 1,104 | $15.70 | $17,332.80 | New | +65.7% | +80.0% | |
| Aug 20, 2024 | Davidson Michael H.65 | Chief Executive Officer | Buy | 5,000 | $16.27 | $81,350.00 | +2.4% | +51.9% | +49.8% |